1959
DOI: 10.1002/1529-0131(195910)2:5<403::aid-art1780020505>3.0.co;2-i
|View full text |Cite
|
Sign up to set email alerts
|

A 15 month controlled study of the effects of amodiaquin (camoquin) in rheumatoid arthritis

Abstract: The Systemic and Articular Indexes of Lansbury were utilized in a study of the effects of amodiaquin on 29 patients with rheumatoid arthritis. Significant beneficial effects were demonstrated when the drug was administered over a period of several months. Toxic effects of this agent are emphasized.Le indices systemic e articular de Lansbury esseva utilisate in un studio del effectos de Amodiaquina in 29 patientes con arthritis rheumatoide. Significative eff ectos benefic esseva demonstrate quando le droga esse… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

1960
1960
2013
2013

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 17 publications
(4 citation statements)
references
References 7 publications
0
4
0
Order By: Relevance
“…Chloroquineresistant malaria is increasingly common in east Africa (Brandling-Bennett et al, 1988), and has been documented in Zambia and Nigeria. However, (Booth et al, 1967;Glick, 1957;Kennedy, 1955;Lind et al, 1973;Love et al, 1953;Perry et al, 1962) and hepatitis (Bepler et al, 1959;Pomeroy et al, 1959) have appeared since the drug's first use. In 1986 several reports of serious reactions to prophylactic AQ (Carr, 1986;Hatton et al, 1986;Neftel et al, 1986;Rhodes et al, 1986) caused the principal manufacturer to withdraw the compound from preventative use, and to date there have been no reports of serious toxicity to AQ in malaria patients.…”
Section: Discussionmentioning
confidence: 99%
“…Chloroquineresistant malaria is increasingly common in east Africa (Brandling-Bennett et al, 1988), and has been documented in Zambia and Nigeria. However, (Booth et al, 1967;Glick, 1957;Kennedy, 1955;Lind et al, 1973;Love et al, 1953;Perry et al, 1962) and hepatitis (Bepler et al, 1959;Pomeroy et al, 1959) have appeared since the drug's first use. In 1986 several reports of serious reactions to prophylactic AQ (Carr, 1986;Hatton et al, 1986;Neftel et al, 1986;Rhodes et al, 1986) caused the principal manufacturer to withdraw the compound from preventative use, and to date there have been no reports of serious toxicity to AQ in malaria patients.…”
Section: Discussionmentioning
confidence: 99%
“…The corticosteroids failed to antagonize bradykinin and so did chloroquine and amodiaquine, which are reported to be useful in rheumatoid arthritis (Haydu, 1953;Freedman, 1956;Pomeroy, Warren, Mills, and Clark, 1959;Bepler, Baier, McCracken, Rentschler, Rogers, and Lansbury, 1959;Kersley and Palin, 1959). Chen and Weston (1960) …”
Section: Discussionmentioning
confidence: 99%
“…to chloroquine has been used in the treatment and prevention of malaria, as well as in the treatment of diseases such as rheumatoid arthritis and lupus erythematosus [18,19]. It was encouraged for use at the time only in chloroquine resistant areas [20] largely due to its propensity to induce agranulocytosis in people when administered for malaria prophylaxis.…”
Section: Introductionmentioning
confidence: 99%